RxDoctor Payments Data

Iulius Grecu, MD

Psychiatry · Spokane, WANPI 1144724683

Payments from drug & device makers

$357in general payments, 2019–2025

Across 13 payments — averaging $27.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$107
  • Neurocrine Biosciences, Inc.$54
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$45
  • Lundbeck LLC$40
  • Teva Pharmaceuticals USA, Inc.$37
  • Axsome Therapeutics, Inc.$31
  • plus $43 from 2 others

What the payments were for

  • Food & beverage$357100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$357 in reported general payments places this provider in the 75th percentile of 576 psychiatry providers in Washington.

See all psychiatry providers in Washington

Medicare billing

Part B allowed, 2024
$6,274
Medicare patients
12
Services billed
60

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate20$66,582
AristadaAripiprazole Lauroxil18$64,212
VraylarCariprazine Hcl34$46,022
RexultiBrexpiprazole26$39,527
BelsomraSuvorexant20$8,873
DayvigoLemborexant21$6,957
Lurasidone Hcl52$6,549
Divalproex Sodium ErDivalproex Sodium64$5,738
VyvanseLisdexamfetamine Dimesylate14$5,467
Clozapine86$4,936
Chlorpromazine Hcl28$2,979
Prazosin Hcl138$2,939
Duloxetine Hcl76$2,910
Quetiapine Fumarate94$2,370
Aripiprazole107$2,282

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$107$66,58220 claims
Alkermes, Inc.Aristada$15$64,21218 claims
Otsuka America Pharmaceutical, Inc.Rexulti$28$39,52726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 576 psychiatry providers in Washington.

Other psychiatry in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →